MPC-7869

DRUG3 trials

Sponsors

Myrexis Inc.

Conditions

Alzheimer DiseaseAlzheimer's DiseaseDementia

Phase 3

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

CompletedNCT00105547

Myrexis Inc.Alzheimer Disease, Dementia

Start: 2005-02-28End: 2008-05-31Updated: 2009-05-05

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

TerminatedNCT00322036

Myrexis Inc.Alzheimer Disease, Dementia

Start: 2006-05-31End: 2008-12-31Updated: 2008-08-05

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

TerminatedNCT00380276

Myrexis Inc.Alzheimer's Disease

Start: 2006-09-30End: 2008-12-31Target: 1000Updated: 2008-08-05

Related Papers

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

2009-12-01453 citations